Admission Date:  [**2134-11-20**]       Discharge Date:  Date of Birth:   [**2072-3-5**]       Sex:  F  Service:  [**Company 191**] CHIEF COMPLAINT:  Shortness of breath  HISTORY OF PRESENT ILLNESS:  62-year-old African-American female with a history of diabetes, rheumatoid arthritis, hypertension, and Stage IV non-small cell lung carcinoma, who breath.
The patient was started on heparin, and echocardiogram was performed at the bedside, demonstrating right ventricular dilatation and paroxysmal subtotal wall motion.
Stage IV non-small cell lung carcinoma, diagnosed in [**2134-8-8**].
The patient had right upper lobe mass with right-sided pleural effusions, for which she underwent pleuroscopy and pleurodesis.
She has been on gemcitabine/cisplatin chemotherapy three times, last on [**2134-11-19**].
Cozaar 100 mg by mouth once daily 2.
Folate 2 mg by mouth once daily 3.
Lipitor 10 mg by mouth once daily 4.
Glyburide 10 mg by mouth once daily 5.
Methotrexate 2.5 mg four times per week 7.
Albuterol 9.
Azmacort 10.
Pulmonary embolism:  The patient had a right internal jugular placed and was started on heparin.
The patient's heparin was discontinued.
The patient then underwent inferior vena cava filter placement with Trap-Ease type filter.
Heparin was continued to be held secondary to bleeding and thrombocytopenia risk.
Anemia:  The patient suffered bleed on heparin at supratherapeutic level.
The patient was transfused four units of packed red blood cells with increase of hematocrit to 26.
It was unclear if this was due to heparin or to the chemotherapy the patient had received several days earlier.
Heparin-induced antibody was negative, as well as other medications such as TPI were stopped.
The patient was started on metoprolol 12.5 mg by mouth twice a day, with close attention to her blood pressure.
Diabetes mellitus:  The patient was discontinued on her oral antihyperglycemics, and she was followed with a regular insulin sliding scale.
Non-small cell lung carcinoma:  The patient had been receiving outpatient chemotherapy.
